Business Context and Reporting Period
Universe Pharmaceuticals INC, a foreign private issuer based in Ji'an, Jiangxi, China, filed Form 6-K for the month of March 2021. The filing documents the closing of the Company's initial public offering (IPO) on March 25, 2021.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the mechanics of the IPO.
- Shares Offered: 5,000,000 ordinary shares
- Offering Price: $5.00 per share
- Par Value: $0.003125 per share
- Trading Symbol: UPC (Nasdaq Global Market)
- Trading Commencement: March 23, 2021
Material Changes
The primary material change reported is the transition from a private entity to a publicly traded company following the successful closing of its IPO. No comparative financial data or prior period metrics are included in this filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond standard legal disclaimers. It notes that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful without registration.
Investor Verification Checklist
- Verify the final closing price and total gross proceeds of the IPO in the attached press releases (Exhibits 99.1 and 99.2).
- Confirm the underwriting agreement terms and any over-allotment options exercised.
- Review the Company's Form 20-F for audited financial statements, as this 6-K does not contain financial data.
- Check for any lock-up agreements or insider selling restrictions associated with the IPO.